A phase II study of raltitrexed (‘Tomudex’ ) in patients with hepatocellular carcinoma
1997; Elsevier BV; Volume: 8; Issue: 5 Linguagem: Inglês
10.1023/a
ISSN1569-8041
AutoresP Rougier, Michel Ducreux, David J. Kerr, Brian I. Carr, Éric François, Antoine Adenis, Leonard W. Seymour,
Tópico(s)Viral-associated cancers and disorders
ResumoP. Rougier, M. Ducreux, D. Kerr, B. I. Carr, E. Francois, A. Adenis & L. Seymour 'instilut Gustave Roussy, Villejuif, France; 2 Department of Medical Oncology, University of Birmingham, Edgbaston, Birmingham, UK; 3 Division of Liver Transplantation, Pittsburgh, PA, USA; Centre Antoine Lacassagne, Nice, Centre Oscar Lambert, Lille, France; Zeneca Pharmaceuticals Ltd., Macclesfield, Cheshire, UK **See page 501 for list of participating investigators
Referência(s)